T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVAC
2576
DELISTED
Intevac Inc
IVAC
| $169K | ﹤0.01% |
26,100
+3,900
| +18% | +$20.9K |
|
2577
Kopin
KOPN
$898M
| $168K | ﹤0.01% |
135,400
+29,500
| +28% | +$36.5K |
|
2578
Olema Pharmaceuticals
OLMA
$920M
| $168K | ﹤0.01% |
68,500
| – | – |
|
2579
Phathom Pharmaceuticals
PHAT
$743M
| $168K | ﹤0.01% |
14,950
+315
| +2% | +$3.25K |
|
|
LUCK
2580
Lucky Strike Entertainment
LUCK
$930M
| $167K | ﹤0.01% |
12,383
-8,894
| -42% | -$120K |
|
2581
Westwood Holdings Group
WHG
$184M
| $166K | ﹤0.01% |
14,900
| – | – |
|
2582
Xeris Biopharma Holdings
XERS
$1.52B
| $164K | ﹤0.01% |
122,979
+19,370
| +19% | +$27.3K |
|
2583
Perdoceo Education
PRDO
$1.99B
| $163K | ﹤0.01% |
11,746
+1,185
| +11% | +$15.1K |
|
2584
Rigel Pharmaceuticals
RIGL
$762M
| $163K | ﹤0.01% |
10,871
| – | – |
|
|
SELF
2585
Global Self Storage
SELF
$58.9M
| $163K | ﹤0.01% |
33,399
| – | – |
|
2586
Superior Group of Companies
SGC
$210M
| $163K | ﹤0.01% |
+16,207
| New | +$156K |
|
|
MMAT
2587
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $163K | ﹤0.01% |
1,372
-224
| -14% | -$29.6K |
|
2588
Mirion Technologies
MIR
$3.88B
| $160K | ﹤0.01% |
24,234
+2,742
| +13% | +$18.5K |
|
2589
PMV Pharmaceuticals
PMVP
$65.1M
| $160K | ﹤0.01% |
18,339
+475
| +3% | +$5.06K |
|
2590
Quantum Corp
QMCO
$973M
| $160K | ﹤0.01% |
7,320
| – | – |
|
2591
Unisys
UIS
$210M
| $160K | ﹤0.01% |
31,258
+1,005
| +3% | +$6.3K |
|
2592
Yext
YEXT
$613M
| $160K | ﹤0.01% |
24,451
+847
| +4% | +$4.62K |
|
2593
MacroGenics
MGNX
$259M
| $159K | ﹤0.01% |
23,767
+5,612
| +31% | +$30.8K |
|
2594
ProPetro Holding
PUMP
$1.42B
| $159K | ﹤0.01% |
15,293
+1,712
| +13% | +$18K |
|
2595
Rimini Street
RMNI
$470M
| $159K | ﹤0.01% |
41,806
+220
| +0.5% | +$977 |
|
|
RADI
2596
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $159K | ﹤0.01% |
13,484
+571
| +4% | +$5.92K |
|
2597
Alphatec Holdings
ATEC
$1.51B
| $158K | ﹤0.01% |
12,828
+537
| +4% | +$5.41K |
|
2598
Bionano Genomics
BNGO
$13.5M
| $158K | ﹤0.01% |
180
+10
| +6% | +$12.6K |
|
2599
FuboTV Inc
FUBO
$296M
| $158K | ﹤0.01% |
7,575
-996
| -12% | -$36.5K |
|
2600
KVH Industries
KVHI
$143M
| $157K | ﹤0.01% |
15,400
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.